Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_provenance.
- NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_provenance.
- NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_assertion evidence source_evidence_literature NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_provenance.
- NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_assertion SIO_000772 23694968 NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_provenance.
- NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_assertion wasDerivedFrom befree-20150227 NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_provenance.
- NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_assertion wasGeneratedBy ECO_0000203 NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_provenance.